Ryo Koyama‐Nasu

1.3k total citations
30 papers, 972 citations indexed

About

Ryo Koyama‐Nasu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ryo Koyama‐Nasu has authored 30 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Immunology and 12 papers in Oncology. Recurrent topics in Ryo Koyama‐Nasu's work include Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (9 papers) and CAR-T cell therapy research (5 papers). Ryo Koyama‐Nasu is often cited by papers focused on Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (9 papers) and CAR-T cell therapy research (5 papers). Ryo Koyama‐Nasu collaborates with scholars based in Japan, United States and Australia. Ryo Koyama‐Nasu's co-authors include Daniele Guardavaccaro, Michele Pagano, Florian Bassermann, David Frescas, Toshinori Nakayama, Tetsu Akiyama, Motoko Y. Kimura, Yukiko Nasu‐Nishimura, Naoko Tanese and Gregory David and has published in prestigious journals such as Nature, Blood and PLoS ONE.

In The Last Decade

Ryo Koyama‐Nasu

29 papers receiving 964 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryo Koyama‐Nasu Japan 17 659 237 213 170 73 30 972
Megan J. Bywater Australia 12 1.1k 1.6× 278 1.2× 115 0.5× 149 0.9× 71 1.0× 24 1.3k
Sarah A. Best Australia 17 591 0.9× 311 1.3× 173 0.8× 238 1.4× 55 0.8× 39 980
Paul‐Joseph Aspuria United States 13 547 0.8× 242 1.0× 110 0.5× 197 1.2× 45 0.6× 22 808
Niranjan Yanamandra United States 18 441 0.7× 265 1.1× 122 0.6× 265 1.6× 76 1.0× 28 823
Chiara Balestrieri Italy 11 738 1.1× 253 1.1× 153 0.7× 496 2.9× 60 0.8× 19 1.1k
Magali Herrant France 10 637 1.0× 200 0.8× 179 0.8× 95 0.6× 106 1.5× 11 883
Sébastien Jauliac France 12 715 1.1× 197 0.8× 180 0.8× 159 0.9× 30 0.4× 16 981
Michael P. Holloway United States 13 774 1.2× 325 1.4× 159 0.7× 96 0.6× 32 0.4× 16 928
Renaud Grépin France 16 601 0.9× 278 1.2× 150 0.7× 278 1.6× 28 0.4× 26 917

Countries citing papers authored by Ryo Koyama‐Nasu

Since Specialization
Citations

This map shows the geographic impact of Ryo Koyama‐Nasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Koyama‐Nasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Koyama‐Nasu more than expected).

Fields of papers citing papers by Ryo Koyama‐Nasu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Koyama‐Nasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Koyama‐Nasu. The network helps show where Ryo Koyama‐Nasu may publish in the future.

Co-authorship network of co-authors of Ryo Koyama‐Nasu

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Koyama‐Nasu. A scholar is included among the top collaborators of Ryo Koyama‐Nasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Koyama‐Nasu. Ryo Koyama‐Nasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Endo, Yukihiro, Atsushi Onodera, Seiji Mita, et al.. (2025). SLAMF6 regulates basal T cell receptor signaling and influences invariant natural killer T cell lineage diversity. International Immunology. 37(9). 567–581. 1 indexed citations
2.
Koyama‐Nasu, Ryo, Motoko Y. Kimura, Masahiro Kiuchi, et al.. (2023). CD69 Imposes Tumor-Specific CD8+ T-cell Fate in Tumor-Draining Lymph Nodes. Cancer Immunology Research. 11(8). 1085–1099. 13 indexed citations
3.
Yagi, Ryoji, Yukihiro Endo, Ryo Koyama‐Nasu, et al.. (2021). IFNγ suppresses the expression of GFI1 and thereby inhibits Th2 cell proliferation. PLoS ONE. 16(11). e0260204–e0260204. 6 indexed citations
4.
Suzuki, Akane, Ryoji Yagi, Motoko Y. Kimura, et al.. (2020). Essential Role for CD30-Transglutaminase 2 Axis in Memory Th1 and Th17 Cell Generation. Frontiers in Immunology. 11. 1536–1536. 7 indexed citations
5.
Koyama‐Nasu, Ryo, Mariko Takami, Takahiro Aoki, et al.. (2020). CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy. Cancer Immunology Immunotherapy. 70(5). 1239–1254. 23 indexed citations
6.
Kotaki, Ryutaro, M. Kawashima, Asuka Yamaguchi, et al.. (2020). Overexpression of miR-669m inhibits erythroblast differentiation. Scientific Reports. 10(1). 13554–13554. 10 indexed citations
7.
Aoki, Takahiro, Mariko Takami, Tomozumi Takatani, et al.. (2020). Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d‐independent manner. Cancer Science. 111(7). 2223–2233. 12 indexed citations
8.
Endo, Yusuke, Atsushi Onodera, Kazushige Obata‐Ninomiya, et al.. (2019). ACC1 determines memory potential of individual CD4+ T cells by regulating de novo fatty acid biosynthesis. Nature Metabolism. 1(2). 261–275. 63 indexed citations
9.
Kimura, Motoko Y., Ryo Koyama‐Nasu, Ryoji Yagi, & Toshinori Nakayama. (2019). A new therapeutic target: the CD69-Myl9 system in immune responses. Seminars in Immunopathology. 41(3). 349–358. 36 indexed citations
10.
Kimura, Motoko Y., Koji Hayashizaki, Ryo Koyama‐Nasu, et al.. (2018). Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells. International Immunology. 30(12). 559–567. 69 indexed citations
11.
Kotaki, Ryutaro, Hiroshi Higuchi, Jun Ogata, et al.. (2017). Imbalanced expression of polycistronic miRNA in acute myeloid leukemia. International Journal of Hematology. 106(6). 811–819. 4 indexed citations
12.
Ito, Toshihiro, Kiyoshi Hirahara, Atsushi Onodera, et al.. (2017). Anti-tumor immunity via the superoxide-eosinophil axis induced by a lipophilic component ofMycobacteriumlipomannan. International Immunology. 29(9). 411–421. 9 indexed citations
13.
Kozuka‐Hata, Hiroko, Ryo Koyama‐Nasu, Kouhei Tsumoto, et al.. (2015). Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (TGFBR2) as a Novel Regulator of Glioblastoma Stem Cell Properties. Molecular & Cellular Proteomics. 15(3). 1017–1031. 17 indexed citations
14.
Koyama‐Nasu, Ryo, Tomoatsu Hayashi, Yukiko Nasu‐Nishimura, Tetsu Akiyama, & Ryuya Yamanaka. (2015). Thr160 of Axin1 is critical for the formation and function of the β-catenin destruction complex. Biochemical and Biophysical Research Communications. 459(3). 411–415. 6 indexed citations
15.
Hiraoka, Koji, et al.. (2015). SOX9-mediated upregulation of LGR5 is important for glioblastoma tumorigenicity. Biochemical and Biophysical Research Communications. 460(2). 216–221. 16 indexed citations
16.
Takai, Hiroki, Tomohiro Sato, Yuriko Sakaguchi, et al.. (2014). 5-Hydroxymethylcytosine Plays a Critical Role in Glioblastomagenesis by Recruiting the CHTOP-Methylosome Complex. Cell Reports. 9(1). 48–60. 108 indexed citations
17.
Koyama‐Nasu, Ryo, Rina Takahashi, Satoshi Yanagida, et al.. (2013). The Cancer Stem Cell Marker CD133 Interacts with Plakoglobin and Controls Desmoglein-2 Protein Levels. PLoS ONE. 8(1). e53710–e53710. 13 indexed citations
18.
Koyama‐Nasu, Ryo, Yukiko Nasu‐Nishimura, Kenzui Taniue, et al.. (2013). The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells. Oncogene. 33(17). 2236–2244. 30 indexed citations
19.
Funato, Kosuke, Yukiko Nasu‐Nishimura, Kanae Echizen, et al.. (2011). Abstract LB-104: The histone deacetylase SIRT2 regulates the cell proliferation and tumorigenicity of glioblastoma cancer stem cells. Cancer Research. 71(8_Supplement). LB–104. 1 indexed citations
20.
Koyama‐Nasu, Ryo, Gregory David, & Naoko Tanese. (2007). The F-box protein Fbl10 is a novel transcriptional repressor of c-Jun. Nature Cell Biology. 9(9). 1074–1080. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megan J. Bywater Breakdown of academic impact, for papers by Sarah A. Best Breakdown of academic impact, for papers by Paul‐Joseph Aspuria Breakdown of academic impact, for papers by Niranjan Yanamandra Breakdown of academic impact, for papers by Chiara Balestrieri Breakdown of academic impact, for papers by Magali Herrant Breakdown of academic impact, for papers by Sébastien Jauliac Breakdown of academic impact, for papers by Michael P. Holloway Breakdown of academic impact, for papers by Renaud Grépin
Rankless by CCL
2026